Belgium’s thriving biotech and life science sector is fuelled by the work of more than 300 biopharmaceutical companies, with the country renowned for its expertise in pharmaceuticals, diagnostics, and medical technology. This article presents six rising biotech firms; AgomAb Therapeutics, developing antibody treatments for fibrosis; Confo Therapeutics, focusing on drugs targeting G protein-coupled receptors; Imcyse, a spin-off from KU Leuven which offers immunotherapies for autoimmune diseases; Mithra Pharmaceuticals, specializing in women’s health solutions; MRM Health, harnessing the gut microbiome for therapies treating inflammatory, CNS, and metabolic diseases; and Precirix, advancing its radiopharmaceuticals portfolio.
The future of cell & gene therapy: Key trends to watch
Cell and gene therapies are moving towards correcting root causes of diseases. Let’s take a look at future cell and gene therapy trends. The post The
![[Webinar] How to Close Identity Gaps in 2026 Before AI Exploits Enterprise Risk](https://i3.wp.com/blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgRHgJL0SczODx5PAnF85b8b0mRpiOOkIQdOWvhivyXu6H8UeZKH9ZUdaeW5IuU59q2hjMNioQWQ5vk1Km8yinGGc8GA079qvhTtFsp9PV76Kmp-3lpKh2zi3vgd_-6dFcOI6i1YHs7VkJ-p-HvOEuOwkjooBVSvYFOrVqXqNhZShZy3IUeD6BVHVvUIj50/s1700-e365/webinar-cerby.jpg?w=0&resize=0,0&ssl=1 "[Webinar] How to Close Identity Gaps in 2026 Before AI Exploits Enterprise Risk")
